France Pharmacogenetic Testing Market to 2032
Overview
The France Pharmacogenetic Testing Market is expected to reach a 553.01 USD Million by 2032 and is projected to grow at a CAGR of 11.30% from 2025 to 2032.
Revenue, 2024 (USD Million)
297.75
Forecast, 2032 (USD Million)
553.01
CAGR, 2024 - 2032
11.30%
Report Coverage
France
France Pharmacogenetic Testing Market 2018-2032 USD Million
France Pharmacogenetic Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 297.75 USD Million
- Projected Market Size (2032): 553.01 USD Million
- CAGR (2025-2032): 11.30%
Key Findings of France Pharmacogenetic Testing Market
- The France Pharmacogenetic Testing Market was valued at 297.75 USD Million in 2024.
- The France Pharmacogenetic Testing Market is likely to grow at a CAGR of 11.30% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Blood in Sample Segment accounted for the largest share of the market with a revenue of 160.50 USD Million
- The fastest growing segment CYP2C19 in Gene Segment grew Fastest with a CAGR of 16.08% during the forecast period from 2024 to 2032.
France Pharmacogenetic Testing Market Scope
France Pharmacogenetic Testing Market Segmentation & Scope
Type
- Single Gene Tests
- Array-Based Tests
- Whole Exome Sequencing
- Whole Genome Sequencing
Gene
- Others
- TMPT
- HTR2A/C
- SLC6A4
- D4D4
- DRD3
- ONCOTYPE DX® AND MAMMAPRINT®
- OPRM1
- CYP2D
- HLA-B*5701
- HLA-B*1502
- CYP1A2
- CYP2C9 AND VKORC1
- CYP2D6
- CYP2C19
Drug
- Over-the-Counter Medications
- Vitamins
- Herbal Supplements
- Recreational Drugs
- Nutraceuticals
- Prescription Drugs
Distribution Channel
- Direct-to-Customer Services
- Mail-Order Pharmacies
- Retail Pharmacies
- Hospital Pharmacy
Therapeutic Area
- Others
- Neurology
- Oncology
- Gynecology
- Dermatology
- Immunology & Hypersensitivity
- Endocrinology
- Genomics
- Anesthesiology
- Gastroenterology
- Cardiology
Sample
- Saliva
- Blood
Application
- Drug Regulation
- Drug Development
- Clinical Practice
End User
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
France Pharmacogenetic Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 297.75 USD Million |
| Market Value in 2032 | 553.01 USD Million |
| CAGR (2025-2032) | 11.30% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Gene,Drug,Distribution Channel,Therapeutic Area,Sample,Application,End User |
Regional Insights:
-
Leading Market (2024-2032): France, leading in terms of revenue 297.75 USD Million in 2024
- Key Country: France, leading in terms of revenue with value of 297.75 USD Million in 2024.
Segments and Scope
-
France Pharmacogenetic Testing Market to 2032, By Type
- Whole Genome Sequencing is the largest segment in France Pharmacogenetic Testing Market to 2032 with a revenue of 139.71 USD Million in the year 2024.
- Whole Genome Sequencing is the Fastest growing segment in France Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.92 % in forecast period 2025-2032.
-
France Pharmacogenetic Testing Market to 2032, By Gene
- CYP2C19 is the largest segment in France Pharmacogenetic Testing Market to 2032 with a revenue of 41.89 USD Million in the year 2024.
- CYP2C19 is the Fastest growing segment in France Pharmacogenetic Testing Market to 2032 with a Growth rate of 16.08 % in forecast period 2025-2032.
-
France Pharmacogenetic Testing Market to 2032, By Drug
- Prescription Drugs is the largest segment in France Pharmacogenetic Testing Market to 2032 with a revenue of 89.18 USD Million in the year 2024.
- Prescription Drugs is the Fastest growing segment in France Pharmacogenetic Testing Market to 2032 with a Growth rate of 12.69 % in forecast period 2025-2032.
-
France Pharmacogenetic Testing Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in France Pharmacogenetic Testing Market to 2032 with a revenue of 131.93 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in France Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.94 % in forecast period 2025-2032.
-
France Pharmacogenetic Testing Market to 2032, By Therapeutic Area
- Cardiology is the largest segment in France Pharmacogenetic Testing Market to 2032 with a revenue of 53.26 USD Million in the year 2024.
- Cardiology is the Fastest growing segment in France Pharmacogenetic Testing Market to 2032 with a Growth rate of 15.31 % in forecast period 2025-2032.
-
France Pharmacogenetic Testing Market to 2032, By Sample
- Blood is the largest segment in France Pharmacogenetic Testing Market to 2032 with a revenue of 160.50 USD Million in the year 2024.
- Blood is the Fastest growing segment in France Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.50 % in forecast period 2025-2032.
-
France Pharmacogenetic Testing Market to 2032, By Application
- Clinical Practice is the largest segment in France Pharmacogenetic Testing Market to 2032 with a revenue of 131.55 USD Million in the year 2024.
- Clinical Practice is the Fastest growing segment in France Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.86 % in forecast period 2025-2032.
-
France Pharmacogenetic Testing Market to 2032, By End User
- Healthcare Providers is the largest segment in France Pharmacogenetic Testing Market to 2032 with a revenue of 116.91 USD Million in the year 2024.
- Healthcare Providers is the Fastest growing segment in France Pharmacogenetic Testing Market to 2032 with a Growth rate of 12.12 % in forecast period 2025-2032.
France Pharmacogenetic Testing Market Company Share Analysis
| Company Name |
|
||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Sonic Healthcare Limited | |||
| BGI | |||
France Pharmacogenetic Testing Market Geographical Sales Distribution, 2018-2032 USD Million
France Pharmacogenetic Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The France Pharmacogenetic Testing Market is segmented based on Segmentation Type,Gene,Drug,Distribution Channel,Therapeutic Area,Sample,Application,End User.
France Pharmacogenetic Testing Market was valued at USD 297.75(Revenue in USD Million) in 2021.
France Pharmacogenetic Testing Market is projected to grow at a CAGR of 11.30% during the forecast period of 2024 to 2032.
The Blood segment is expected to dominate the France Pharmacogenetic Testing Market, holding a largest market share of 160.50 USD Million in 2024
France Pharmacogenetic Testing Market Scope
France Pharmacogenetic Testing Market Segmentation & Scope
Type
- Single Gene Tests
- Array-Based Tests
- Whole Exome Sequencing
- Whole Genome Sequencing
Gene
- Others
- TMPT
- HTR2A/C
- SLC6A4
- D4D4
- DRD3
- ONCOTYPE DX® AND MAMMAPRINT®
- OPRM1
- CYP2D
- HLA-B*5701
- HLA-B*1502
- CYP1A2
- CYP2C9 AND VKORC1
- CYP2D6
- CYP2C19
Drug
- Over-the-Counter Medications
- Vitamins
- Herbal Supplements
- Recreational Drugs
- Nutraceuticals
- Prescription Drugs
Distribution Channel
- Direct-to-Customer Services
- Mail-Order Pharmacies
- Retail Pharmacies
- Hospital Pharmacy
Therapeutic Area
- Others
- Neurology
- Oncology
- Gynecology
- Dermatology
- Immunology & Hypersensitivity
- Endocrinology
- Genomics
- Anesthesiology
- Gastroenterology
- Cardiology
Sample
- Saliva
- Blood
Application
- Drug Regulation
- Drug Development
- Clinical Practice
End User
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
Frequently Asked Questions
The France Pharmacogenetic Testing Market is segmented based on Segmentation Type,Gene,Drug,Distribution Channel,Therapeutic Area,Sample,Application,End User.
France Pharmacogenetic Testing Market was valued at USD 297.75(Revenue in USD Million) in 2021.
France Pharmacogenetic Testing Market is projected to grow at a CAGR of 11.30% during the forecast period of 2024 to 2032.
The estimated market value of the France Pharmacogenetic Testing Market for final year is USD 553.01 (USD Million).
France Pharmacogenetic Testing Market Company Profiling
Frequently Asked Questions
The France Pharmacogenetic Testing Market is segmented based on Segmentation Type,Gene,Drug,Distribution Channel,Therapeutic Area,Sample,Application,End User.
France Pharmacogenetic Testing Market was valued at USD 297.75(Revenue in USD Million) in 2021.
France Pharmacogenetic Testing Market is projected to grow at a CAGR of 11.30% during the forecast period of 2024 to 2032.
The estimated market value of the France Pharmacogenetic Testing Market for final year is USD 553.01 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.